MAPT and Alzheimer disease: While the mechanisms underpinning the observed affect remain unclear and validation in additional tau mouse models and ultimately humans is required, the findings presented here further add to the existing evidence that EC has promise as a multi-modal AD therapeutic potentially as a supplement to a flavanol-3-ol rich diet.